Status | Study |
Active, not recruiting |
Study Name: Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone Condition: Polycystic Ovary Syndrome Hyperandrogenism Date: 2011-08-30 Interventions: Drug: Metformin 500-2000 mg PO |
Recruiting |
Study Name: Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone Condition: Polycystic Ovary Syndrome Hyperandrogenism Date: 2011-08-30 Interventions: Drug: Progesterone Subjects wi |
Completed |
Study Name: Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone Condition: Polycystic Ovary Syndrome Hyperandrogenism Date: 2011-08-29 Interventions: Drug: Flutamide Subjects weigh |
Recruiting |
Study Name: Effect of Metformin on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess Condition: Obesity Hyperandrogenemia Polycystic Ovary Syndrome Date: 2011-08-22 Interventions: Drug: Metformin 500-1000 mg PO BID (X12 weeks) Other |
Not yet recruiting |
Study Name: Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess Condition: Hyperandrogenemia Obesity Polycystic Ovary Syndrome Date: 2011-08-19 Interventions: Drug: Hydrocortisone 10 mg/m2/per day PO at bedtime (X4 weeks) |
Not yet recruiting |
Study Name: Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess Condition: Hyperandrogenemia Obesity Polycystic Ovary Syndrome Date: 2011-08-19 Interventions: Drug: Leuprolide depot leuprolide 11.25 mg if less than or equal to 37.5 kg or 15 mg if > 37.5 kg im |
Recruiting |
Study Name: Ovarian Contribution to Androgen Production in Adolescent Girls Condition: Polycystic Ovary Syndrome Obesity Hy Date: 2011-08-17 Interventions: Drug: Dexamethasone 1 mg PO |
Completed |
Study Name: Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism Condition: Polycystic Ovary Syndrome Date: 2011-05-25 Interventions: Drug: 3 mg DRSP/20 μg EE 1 pill daily-24 days of drospirenone 3 mg (3 mg DRSP)/ethinyl estradiol 20 |
Completed |
Study Name: Obesity and Clinical Presentation of Hyperandrogenism Condition: Polycystic Ovary Syndrome Date: 2010-04-29 |
Active, not recruiting |
Study Name: Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome Condition: Polycystic Ovary Syndrome Date: 2009-11-24 Interventions: Drug: Rosiglitazone 4 mg twice |